Pages
Products

Human WNT5A adenoviral particles

For research use only. Not intended for any clinical use.

Cat. No. :   AD00276Z

Storage :   -80℃ Shipping :   Frozen on dry ice

Titer: Size:

Inquire for Price

Virus Particles Information

Quality Control

Gene Information

Cat. No. AD00276Z
Product Type Adenoviral particle
Gene WNT5A
Species Human
Titer Varies lot by lot, for example, ≥1x10^10 IFU/mL, ≥1x10^11 IFU/mL, ≥1x10^11 VP/mL etc.
Size Varies lot by lot, for example, 100 ul, 500 ul, 1 mL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Summary Creative Biogene ensures high-quality adenovirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between adenovirus particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in adenovirus production, especially for applications in animal studies and gene therapy. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced adenovirus particles to ensure regulatory compliance.
Sterility Creative Biogene ensures that adenovirus products are free of any bacterial, fungal and other microbial contamination.
Ad5 E1 Detection All Creative Biogene adenoviruses are PCR tested to ensure that there are no detectable E1 sequences in the particles, which could be from revertants or external E1 contamination.
RCA Assays Adenovirus products originating at Creative Biogene are guaranteed to have undetectable replication-competent adenovirus (RCA). This quality control measure is important because there is always the possibility of wild-type contamination due to revertants or environmental sources.
PFU Titering All purified adenovirus preparations are tested for infectious titer. Creative Biogene's PFU test takes a few days longer but counts true plaques in HEK cells rather than estimating PFU titers via IHC staining or TCI50 of infected cells.
Gene Name WNT5A wingless-type MMTV integration site family, member 5A [ Homo sapiens ]
Gene Symbol WNT5A
Synonyms WNT5A; wingless-type MMTV integration site family, member 5A; protein Wnt-5a; hWNT5A; WNT 5A protein; WNT-5A protein;
Gene ID 7474
Uni Prot ID P41221
m RNA Refseq BC064694
Chromosome Location 3p21-p14
Function cytokine activity; frizzled binding; frizzled-2 binding; protein domain specific binding; receptor agonist activity; receptor binding; receptor tyrosine kinase-like orphan receptor binding; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding;
Pathway Basal cell carcinoma, organism-specific biosystem; Basal cell carcinoma, conserved biosystem; Class B/2 (Secretin family receptors), organism-specific biosystem; DNA damage response (only ATM dependent), organism-specific biosystem; GPCR ligand binding, organism-specific biosystem; HTLV-I infection, organism-specific biosystem; HTLV-I infection, conserved biosystem;
MIM 164975
Quick Inquiry

Background

Case Study

Q & A

Customer Reviews

The WNT5A gene encodes a secreted glycoprotein belonging to the Wnt family that plays a key role in developmental processes, cell proliferation, and tissue homeostasis. As a non-canonical Wnt ligand, WNT5A primarily activates β-catenin-independent signaling pathways, such as the planar cell polarity (PCP) pathway and the Wnt/Ca²⁺ pathway. It is essential for embryogenesis, limb development, and organogenesis, and its dysregulation is associated with cancer, inflammation, and metabolic disorders. The function of WNT5A is context-dependent, and it can act as both an oncogene and a tumor suppressor depending on the cellular context. Its complex signaling mechanism makes it a key target for regenerative medicine, cancer biology, and stem cell differentiation research.

Human WNT5A adenoviral particles are replication-defective viral vectors designed to efficiently deliver the WNT5A gene into mammalian cells. These viral particles exploit the natural tropism of adenoviruses to transduce a wide range of cell types, including primary cells and cells that are difficult to transfect. To ensure safety, the adenoviral backbone is modified to delete essential viral genes (e.g., E1/E3) to prevent replication while housing the WNT5A transgene under a strong promoter (e.g., CMV or EF1α). Following transduction, cells express the WNT5A protein and can be used to study its signaling cascades, cellular responses, or therapeutic potential. Applications include in vitro functional assays, in vivo gene therapy models, and tissue engineering.

microRNA (miR)-374a plays a crucial role in cancer progression by promoting metastasis and proliferation of multiple malignancies. Here, researchers investigated whether miR-374a affects the progression of bladder cancer and investigated the underlying mechanisms. Low levels of miR-374a were associated with poor prognosis in bladder cancer patients with distant metastasis by in silico analysis. WNT5A was a direct target of miR-374a in two bladder cancer cell lines. In T24 and TCCSUP human bladder cancer cells, miR-374a mimics abolished the metastatic potential and invasiveness of bladder cancer cells by downregulating WNT5A; whereas the opposite was observed with miR-374a inhibitors. In addition, miR-374a treatment reduced the phosphorylation and nuclear translocation of β-catenin. Cisplatin treatment significantly increased the rate of apoptosis. The expression levels of cancer stem cell-related proteins were reduced in cells pretreated with miR-374a mimics. Therefore, these studies indicate that miR-374a can improve the tumor biological behavior of bladder cancer cells, suggesting that miR-374a may be a new small molecule therapeutic target.

Here, after the researchers introduced an adenoviral vector overexpressing WNT5A (Ad-WNT5A) into T24 cells, WNT5A transcripts were significantly upregulated (Figure 1A). Functionally, overexpression of WNT5A exacerbated the metastasis and invasiveness of T24 cells in wound healing and Transwell assays (Figure 1B-D). In addition, treatment with miR-374a mimics significantly abolished the metastatic capacity and invasiveness of T24 cells (Figure 1B-D). Therefore, both miR-374 and WNT5A can alter bladder cell biology. To determine whether the effects of miR-374a on cancer cell biology are achieved through WNT5A downregulation, T24 cells overexpressing WNT5A were treated with miR-374a mimics. First, miR-374a mimics significantly abolished the increase in WNT5A (Figure 1B-D). Second, the increased metastasis and invasiveness of T24 cells induced by WNT5A overexpression were also inhibited (Figure 1B-D). Similar results were observed in TCCSUP cells.

Figure 1. miR-374a mimic decreases metastatic and invasive abilities in bladder cancer cells via degeneration of WNT5A.Figure 1. miR-374a mimic decreases metastatic and invasive abilities in bladder cancer cells via degeneration of WNT5A. (Chen X, et al., 2018)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
High Purity & Low Toxicity

The purity of these Human WNT5A adenoviral particles was exceptional, resulting in minimal cellular toxicity in my HEK293 cells. This allowed for cleaner experimental outcomes and reliable data interpretation.

Germany

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction